Azasteroids as Promising Neuromuscular Blockers: A Review

Article history: Received on: 15/10/2012 Revised on: 28/10/2012 Accepted on: 04/10/2012 Available online: 30/11/2012 Neuromuscular blockers are used during surgery with anesthesia to cause relaxation of muscles and control muscle movements. The purpose of this review is to focus on the synthesis and pharmacological activity of the neuromuscular blockers, to compare the main differences between the available polarizing and nondepolarizing neuromuscular blockers. Continuous improvement of knowledge about neuromuscular blockers in respect to synthesis, their pharmacology, adverse effects, and toxic effects were unanswered questions about neuromuscular junction and neuromuscular blockade in children is essential for the correct use of these drugs. In this review article, structure-activity relationships within polarizing and nondepolarizing neuromuscular blockers have been reviewed.

[1]  T. Speight,et al.  Pancuronium Bromide: A Review of its Pharmacological Properties and Clinical Application , 2012, Drugs.

[2]  A. Harvey,et al.  Synthesis of quaternary ammonium salts of 16E-[4-(2-alkylaminoethoxy)-3-methoxybenzylidene]androstene derivatives as skeletal muscle relaxants , 2011, Steroids.

[3]  Randhir Singh,et al.  Synthesis and neuromuscular blocking activity of 16-(2- and 3-pyridylmethylene) dehydroepiandrosterone derivatives , 2010, Steroids.

[4]  K. McGoldrick,et al.  General anesthesia for ophthalmic surgery. , 2006, Ophthalmology clinics of North America.

[5]  T. Vree,et al.  Org-NC45: a new steroidal non-depolarizing muscle relaxant , 1982, Pharmaceutisch Weekblad.

[6]  M. Davis,et al.  Muscle-relaxant properties of a steroid bis-quaternary ammonium salt , 1964, Experientia.

[7]  O. Nedergaard.  Curare: the flying death. , 2003, Pharmacology & toxicology.

[8]  H. Fajrak,et al.  Synthesis and Neuromuscular Blocking Activity of 16β-N-Methylpiperazino Steroidal Derivatives (I). , 2003 .

[9]  D. P. Jindal,et al.  Synthesis and neuromuscular blocking activity of 16beta-N-methylpiperazino steroidal derivatives. , 2002, European journal of medicinal chemistry.

[10]  T. Raghavendra.  Neuromuscular Blocking Drugs: Discovery and Development , 2002, Journal of the Royal Society of Medicine.

[11]  R. Giridhar,et al.  New Azasteroidal Neuromuscular Blocking Agent Possessing Acetylcholine‐Like Moiety in Ring‐A , 2001 .

[12]  Chingmuh Lee,et al.  Structure, conformation, and action of neuromuscular blocking drugs. , 2001, British journal of anaesthesia.

[13]  D. P. Jindal,et al.  Synthesis and neuromuscular blocking activity of 16beta-piperidinosteroidal derivatives. , 2001, European journal of medicinal chemistry.

[14]  A. McKenzie.  Prelude to pancuronium and vecuronium , 2000, Anaesthesia.

[15]  D. Bevan.  Rapacuronium. Introduction. , 2000, Anesthesia and analgesia.

[16]  C. Strange,et al.  Comparison of train-of-four and best clinical assessment during continuous paralysis. , 1997, American journal of respiratory and critical care medicine.

[17]  S. Feldman.  NEUROMUSCULAR BLOCK , 1954, Anaesthesia and intensive care.

[18]  H. Parnas,et al.  Open channel and competitive block of the embryonic form of the nicotinic receptor of mouse myotubes by (+)‐tubocurarine. , 1996, The Journal of physiology.

[19]  E. Haxby,et al.  Is rocuronium an exception to the relation between onset and offset? A comparison with pipecuronium. , 1996, European journal of anaesthesiology.

[20]  N. Goudsouzian,et al.  Comparison of neuromuscular, cardiovascular, and histamine-releasing properties of doxacurium and pipecuronium. , 1996, Journal of clinical anesthesia.

[21]  D. P. Jindal,et al.  Synthesis and biological activity of 17-azasteroidal neuromuscular-blocking agents , 1994 .

[22]  W. Buzello,et al.  Variability of pipecuronium neuromuscular blockade , 1993, Acta anaesthesiologica Scandinavica.

[23]  D. P. Jindal,et al.  Steroids and related studies: part 90 — certain new azasteroidal bisquaternary neuromuscular blockers , 1993 .

[24]  S. Basta.  Clinical pharmacology of mivacurium chloride: a review. , 1992, Journal of clinical anesthesia.

[25]  D. P. Jindal,et al.  Heterosteroids and drug research. , 1991, Progress in medicinal chemistry.

[26]  J. Engbaek,et al.  Adverse Reactions and Interactions of the Neuromuscular Blocking Drugs , 1989, Medical toxicology and adverse drug experience.

[27]  H. H. Ali,et al.  Clinical Pharmacology of Doxacurium Chloride A New Long‐acting Nondepolarlzlng Muscle Relaxant , 1988, Anesthesiology.

[28]  W. Bowman,et al.  Structure: action Relationships Among Some Desacetoxy Analogues of Pancuronium and Vecuronium in the Anesthetized Cat , 1988, Anesthesiology.

[29]  D. Mishkin,et al.  Neuromuscular blocking agents. , 1988, Military medicine.

[30]  E. Inada,et al.  Histamine antagonists and d‐tubocurarine‐induced hypotension in cardiac surgical patients , 1986, Clinical pharmacology and therapeutics.

[31]  I. G. Marshall,et al.  Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat. , 1983, British journal of anaesthesia.

[32]  H. Nagashima,et al.  Muscular relaxation with atracurium, vecuronium and duador under balanced anaesthesia. , 1983, British journal of anaesthesia.

[33]  E. Kárpáti,et al.  The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201). , 1981, Arzneimittel-Forschung.

[34]  N. Krieg,et al.  Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man. , 1981, British journal of anaesthesia.

[35]  N. Krieg,et al.  RELATIVE POTENCY OF ORG NC 45, PANCURONIUM, ALCURONIUM AND TUBOCURARINE IN ANAESTHETIZED MAN , 1980 .

[36]  M. Houwertjes,et al.  Comparison of the neuromuscular blocking properties of ORG NC 45 and pancuronium in the rat, cat and rhesus monkey. , 1980, British journal of anaesthesia.

[37]  Z. Tuba.  SYNTHESIS OF 2β,16β-BIS-(4′-DIMETHYL-1′-PIPERAZINO)-3α,17β-DIACETOXY-5.# ALPHA.-ANDROSTANE DIBROMIDE AND RELATED COMPOUNDS , 1980 .

[38]  Fisenko Vp,et al.  On some properties of a new steroid curare-like compound pipecurium bromide. , 1980 .

[39]  E. Kárpáti,et al.  Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide. , 1980, Arzneimittel-Forschung.

[40]  R. Alyautdin,et al.  On some properties of a new steroid curare-like compound pipecurium bromide. , 1980, Arzneimittel-Forschung.

[41]  A. Harvey,et al.  The effects of dihydrochandonium and other chandonium analogues on neuromuscular and autonomic transmission , 1979, The Journal of pharmacy and pharmacology.

[42]  Harkishan Singh,et al.  Neuromuscular and other blocking actions of a new series of mono and bisquaternary aza steroids * , 1974, The Journal of pharmacy and pharmacology.

[43]  D. Paul,et al.  Steroids and related studies. XXV. Chandonium iodide (17a-methyl-3beta-pyrrolidino-17a-aza-D-homoandrost-5-ene dimethiodide) and other quaternary ammonium steroid analogues. , 1974, Journal of the Chemical Society. Perkin transactions 1.

[44]  C. Hewett,et al.  Pancuronium bromide and other steroidal neuromuscular blocking agents containing acetylcholine fragments. , 1973, Journal of medicinal chemistry.

[45]  W. Hespe,et al.  Metabolic fate of the short-acting peripheral neuromuscular blocking agent stercuronium in the rat, as related to its action. , 1971, Biochemical pharmacology.

[46]  R. Clarke,et al.  A CLINICAL COMPARISON OF PANCURONIUM WITH d-TUBOCURARINE , 1971 .

[47]  J. Norman,et al.  THE NEUROMUSCULAR BLOCKING ACTION OF PANCURONIUM IN MAN DURING ANAESTHESIA , 1970 .

[48]  W. Dick,et al.  [Pancuronium bromide. Clinical experiences with a new steroid-like muscle relaxant]. , 1970, Der Anaesthesist.

[49]  J. Norman,et al.  The neuromuscular blocking actions of pancuronium. , 1970, Anaesthesia.

[50]  C. Marjoribanks,et al.  The pharmacology of pancuronium bromide (Org.NA97), a new potent steroidal neuromuscular blocking agent. , 1968, British journal of pharmacology and chemotherapy.

[51]  K. J. Child,et al.  Neuromuscular blocking activities of some steroidal mono and bis-quaternary ammonium compounds with special reference to NN'-dimethylconessine. , 1968, British journal of pharmacology and chemotherapy.

[52]  C. Hewett,et al.  Amino-steroids. Part III. 2- and 3-Amino-5α-androstanes , 1968 .

[53]  Verner Ir.  General anaesthesia for ophthalmic surgery , 1967 .

[54]  A. M. Reid,et al.  The neuromuscular blocking properties of a new steroid compound, pancuronium bromide. A pilot study in man. , 1967, British journal of anaesthesia.

[55]  T. C. Muir,et al.  Steroidal monoquaternary ammonium salts with non‐depolarizing neuromuscular blocking activity , 1967, The Journal of pharmacy and pharmacology.

[56]  D. Biggs,et al.  Neuromuscular blocking properties of stereoisomeric androstane-3,l7-bisquaternary ammonium salts. , 1967, British journal of pharmacology and chemotherapy.

[57]  Michael A. Davis,et al.  Steroid amines. Part IV. 3,17-Diaminoandrostane derivatives , 1967 .

[58]  R. Katz,et al.  The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat. , 1966, The Journal of pharmacology and experimental therapeutics.

[59]  M. Alauddin,et al.  Non‐depolarising neuromuscular blockade by 3α,17α‐bis(quaternary ammonium) 5α‐androstanes , 1965 .

[60]  W. Mapleson,et al.  RELAXANT ACTION IN MAN OF DIPYRANDIUM CHLORIDE (M&B 9105A). (A STEROID BIS-QUATERNARY AMMONIUM SALT). , 1964, British Journal of Anaesthesia.

[61]  M. Alauddin,et al.  BIOLOGICAL ACTIVITY IN STEROIDS POSSESSING NITROGEN ATOMS , 1962, The Journal of pharmacy and pharmacology.

[62]  A. Quevauviller,et al.  [On the toxicity and curarizing power of amalouetine chloride]. , 1960, Annales pharmaceutiques francaises.

[63]  R. Goutarel,et al.  [Steroid alkaloids. V. Alkaloids of Malouetia bequaertiana E. Woodson (Apocynaceae): funtuphyllamine B and malouetine. Preliminary communication]. , 1960, Annales pharmaceutiques francaises.

[64]  P. Kushner.  General anesthesia, for ophthalmic surgery in children. , 1960, American journal of ophthalmology.

[65]  EL-MAGHRABY A EL-F,et al.  A new short-acting muscle relaxant. , 1958, The Journal of the Egyptian Medical Association.